25021-471-66 : NDC 2026 Code

25021-471-66 : Fulvestrant ( Fulvestrant )

Additionally :

You can get information about “25021-471-66” NDC code in 25021-471-66 in HTML format

HTML | 25021-471-66 in TXT (Plain Text) format

TXT | 25021-471-66 in PDF (Portable Document Format)

PDF | 25021-471-66 in XML format

XML formats.

NDC Code : 25021-471-66 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "25021-471-66",
    "PackageDescription": "2 SYRINGE in 1 CARTON (25021-471-66)  / 5 mL in 1 SYRINGE",
    "NDC11Code": "25021-0471-66",
    "ProductNDC": "25021-471",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Fulvestrant",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Fulvestrant",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "INTRAMUSCULAR",
    "StartMarketingDate": "20260415",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA211422",
    "LabelerName": "Sagent Pharmaceuticals",
    "SubstanceName": "FULVESTRANT",
    "StrengthNumber": "50",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-04-15",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260415",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}